AMZN
Amazon.com, Inc.
AMZN has the edge over KBH overall, supported by stronger valuation and stronger modeled upside.
KBH
KB Home
KBH trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
KBH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Strong |
KBH's balance sheet is currently strong, and its profitability is stable, but its revenue and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over KBH in the historical PE scenario, which offers more potential upside but is not a forecast.
KBH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.2x | $18.30 | -62% |
| Fair | 8.7x | $30.92 | -36% |
| Expensive | 11x | $40.58 | -16% |
| Current | 14x | $48.43 | — |
| Forward | 14x | $48.43 | — |
Historical ranges are pointers, not guarantees.
KBH's PE is in its expensive range at 13.6x. Analysts expect earnings to fall, which would put today's price at 14.3x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
KBH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect KBH's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over KBH on earnings, with more consistent year-over-year improvement.
KBH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.39 | -4.4% |
| Q3 2026 | $3.55 | -50% |
| Q2 2026 | $4.11 | -45% |
| Q1 2026 | $5.18 | -37% |
| Q4 2025 | $6.15 | -27% |
| Q3 2025 | $7.10 | -8.9% |
| Q2 2025 | $7.53 | -0.3% |
| Q1 2025 | $8.18 | +11% |
| Q4 2024 | $8.45 | +20% |
KBH's earnings per share have fallen from their peak: $3.55 over the past year, against $9.09 in late 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over KBH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over KBH on profitability, with a higher operating margin.
KBH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | -20% |
| Q2 2026 | $1.1B | -27% |
| Q1 2026 | $1.1B | -23% |
| Q4 2025 | $1.7B | -15% |
| Q3 2025 | $1.6B | -7.5% |
| Q2 2025 | $1.5B | -11% |
| Q1 2025 | $1.4B | -5.2% |
| Q4 2024 | $2B | +19% |
KBH's revenue has slid since its 2024 peak: $1.3B last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | -2.6 points |
| Q2 2026 | 3.4% | -6 points |
| Q1 2026 | 3.7% | -6.3 points |
| Q4 2025 | 7.6% | -4.8 points |
| Q3 2025 | 8.8% | -3 points |
| Q2 2025 | 9.3% | -3.6 points |
| Q1 2025 | 10% | -1.9 points |
| Q4 2024 | 12% | +0.5 points |
KBH's operating margin was 6.3% last quarter, down 2.6 points from the same quarter a year ago, near the bottom of its range since 2019.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
KBH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$145M | -178% |
| Q2 2026 | $22.2M | -86% |
| Q1 2026 | -$138.6M | +$207M |
| Q4 2025 | $290.1M | -18% |
| Q3 2025 | $185.8M | +$285.2M |
| Q2 2025 | $156.9M | +207% |
| Q1 2025 | -$345.5M | -1913% |
| Q4 2024 | $352.6M | +17% |
KBH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
KBH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -974K shares |
| 1 year | -8.8% | -6M shares |
| 3 years | -25% | -21M shares |
| 5 years | -34% | -31.5M shares |
| Available history | -34% | -32.1M shares |
KBH has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50M |
| Q2 2026 | $80.1M |
| Q1 2026 | $50M |
| Q4 2025 | $102.8M |
| Q3 2025 | $188.5M |
| Q2 2025 | $200M |
| Q1 2025 | $50M |
| Q4 2024 | $103.7M |
KBH spent $283M buying back its own shares over the past year, down 48% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
KBH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
KBH has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
KBH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.1 | Neutral |
| Stochastic | 45.0 | Neutral |
KBH's weekly RSI is 45 (neutral) and its Stochastic is 45 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
KBH PE vs Consumer Cyclical Sector
| Metric | KBH | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 24% below |
| PE % | 95 | 47 | 48 pts above |
KBH has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over KBH on trend strength, trading above more of its moving averages.
KBH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.8 | 3.5% above |
| 20 week MA | $51.7 | 6.2% below |
| 50 week MA | $54.4 | 11% below |
| 100 week MA | $57.1 | 15% below |
| 200 week MA | $58.5 | 17% below |
KBH has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 17% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over KBH on returns for 2026, with the stronger performance.
KBH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.9 | $35.9 | +5.7% |
| 2021 | $35.9 | $43.4 | +21% |
| 2022 | $43.4 | $32.1 | -26% |
| 2023 | $32.1 | $62.5 | +94% |
| 2024 | $62.5 | $65.7 | +5.2% |
| 2025 | $65.7 | $57.3 | -13% |
| 2026 YTD | $57.3 | $48.4 | -15% |
KBH has finished higher in four of the last six years. It's down 15% so far in 2026.